Our study highlights important associations between the anemia of CKD and CKD-MBD, and suggests that further studies are warranted to investigate how non-mineral factors influence FGF23 production and metabolism in CKD, and how the treatment of anemia in CKD may affect FGF23 and FGF23-related outcomes. This evidence concerns the gene FGF23 and anemia (phenotype).